FADS2 rs99780 — The Omega Conversion Bottleneck
The FADS2 gene encodes
delta-6 desaturase | The enzyme responsible for the first rate-limiting step
in converting dietary short-chain polyunsaturated fats into their biologically
active long-chain forms — adding a double bond at the 6-position of the fatty
acid chain,
the enzyme that performs the first critical step in converting the essential
fats you eat — linoleic acid (omega-6) from vegetable oils and alpha-linolenic
acid (omega-3) from flaxseed and walnuts — into longer, more biologically
active forms such as arachidonic acid (ARA), eicosapentaenoic acid (EPA), and
ultimately docosahexaenoic acid (DHA). The rs99780 variant is an intronic
single nucleotide polymorphism within the
FADS1-FADS2 gene cluster | A highly conserved genomic region on chromosome
11q12.2 containing FADS1, FADS2, and FADS3 in tandem — the most replicated
GWAS locus for circulating fatty acid levels in humans
on chromosome 11, a region consistently identified as the dominant genetic
determinant of circulating polyunsaturated fatty acid (PUFA) composition
across populations.
The Mechanism
rs99780 does not alter the FADS2 protein sequence — it is located within an
intron. However, as part of the haplotype structure of the FADS cluster, it
tags a regulatory state that influences
FADS2 expression and delta-6 desaturase activity | Intronic and regulatory
variants in the FADS cluster are thought to influence transcription factor
binding and local chromatin state, modulating the amount of FADS2 enzyme
produced rather than its structure or kinetics.
The T allele at rs99780 co-segregates with minor alleles at neighboring FADS
variants (rs174553, rs174575, rs174583) to form a haplotype associated with
reduced FADS2 activity. The consequence of reduced delta-6 desaturase activity
is a systemic shift in PUFA metabolism:
- Omega-6 pathway: Less linoleic acid (LA) is converted to gamma-linolenic acid (GLA) and then to arachidonic acid (ARA), the major omega-6 long-chain PUFA
- Omega-3 pathway: Less alpha-linolenic acid (ALA) is converted to stearidonic acid (SDA) and then toward EPA — reducing endogenous EPA synthesis from plant-based omega-3 sources
The net result is accumulation of precursor fatty acids (LA, ALA) and
depletion of long-chain products (ARA, EPA), a pattern directly measurable
in blood and tissue phospholipids.
The Evidence
The foundational evidence for rs99780 specifically comes from a study by
Xie and Innis | Xie L, Innis SM. Genetic variants of the FADS1 FADS2 gene
cluster are associated with altered (n-6) and (n-3) essential fatty acids in
plasma and erythrocyte phospholipids in women during pregnancy and in breast
milk during lactation. J Nutr, 2008
in 69 pregnant Canadian women. The study directly genotyped rs99780 among
four FADS cluster variants. Women homozygous for the minor alleles at rs99780
showed lower ARA but higher LA in plasma phospholipids and erythrocyte
ethanolamine phospholipids at 16 and 36 weeks of gestation, alongside decreased
product-to-precursor ratios for both omega-6 (ARA/LA) and omega-3 (EPA/ALA)
pathways. In breast milk, TT homozygotes showed significantly lower ARA and EPA —
indicating that the conversion impairment persists through lactation and affects
the fatty acid composition of milk provided to infants.
The broader context for this locus is established by
Tanaka and colleagues | Tanaka T et al. Genome-wide association study of plasma
polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet, 2009
in 1,075 InCHIANTI participants — the landmark GWAS demonstrating that the FADS
chromosome 11 locus explains a remarkable 18.6% of additive variance in
arachidonic acid levels, with genome-wide significant associations extending
across multiple PUFA species. The same cluster harboring rs99780 was the top
hit for EPA levels and several related fatty acids, confirming this region's
central role in PUFA metabolism.
A key clinical dimension emerged from childhood cohort data:
Talaei and colleagues | Talaei M et al. Intake of n-3 polyunsaturated fatty
acids in childhood, FADS genotype and incident asthma. Eur Respir J, 2021
examined 4,543 children from the AVON Longitudinal Study and found that among
minor allele carriers at a linked FADS2 variant (rs1535, in LD with rs99780),
higher EPA+DHA intake in childhood was associated with a 51% reduction in
asthma risk (OR 0.49, 95%CI 0.31–0.79; p-interaction = 0.006). Among major
allele homozygotes — who can efficiently synthesize their own long-chain omega-3
from plant ALA — no protective effect was found (OR 1.43), suggesting that
supplemental EPA/DHA specifically benefits those who cannot make it endogenously.
A review of the evidence by
O'Neill and Minihane | O'Neill CM, Minihane AM. The impact of fatty acid
desaturase genotype on fatty acid status and cardiovascular health in adults.
Proc Nutr Soc, 2017
confirmed the consistent pattern: FADS minor allele carriers have higher plasma
and tissue concentrations of LA and ALA (precursors), lower ARA, lower EPA, and
somewhat lower DHA. Critically, dietary total fat and fatty acid composition
modifies these relationships — indicating that diet can amplify or attenuate the
genetic effect.
Practical Actions
The core implication is straightforward: people carrying the T allele at rs99780
have a genetically limited capacity to convert plant-based omega-3 and omega-6
fatty acids into their long-chain active forms. This makes preformed EPA and DHA
from marine sources or algae supplements more important than for people with
full FADS2 activity. Plant-based omega-3 sources (flaxseed, chia, walnuts) supply
only ALA, which requires the impaired FADS2 → delta-6 desaturase step to reach
EPA. Relying on these sources as the primary omega-3 strategy is insufficient
for T allele carriers.
The gene-nutrient interaction data also suggest that EPA/DHA supplementation
may provide health benefits in T allele carriers that do not apply equally to
CC homozygotes — including potential protection against atopic conditions and
inflammatory outcomes.
Interactions
rs99780 is part of the FADS1-FADS2 haplotype block that includes rs174537 and
rs174547 (both already in the GeneOps platform). These variants are in partial
linkage disequilibrium (LD) and may produce additive effects when co-inherited.
rs174537 (FADS1, in the triglycerides-fatty-acids category) specifically affects
delta-5 desaturase activity — the downstream step converting DGLA to ARA and
ETA to EPA. Carrying impaired alleles at both FADS2 (rs99780) and FADS1
(rs174537/rs174547) compounds the disruption across the full PUFA elongation
cascade, potentially creating a more severe functional omega-3/omega-6 deficiency
than either variant alone.
rs174575 (FADS2) and rs1535 (FADS2) are additional SNPs in the cluster not yet
in the platform that may provide further resolution on FADS2 activity.
Alla genotyper
Normal FADS2 delta-6 desaturase activity
You carry two copies of the reference C allele at rs99780. This is the most common genotype globally, shared by approximately 37% of the population. Your FADS2 gene is in its standard regulatory state, associated with normal delta-6 desaturase activity and efficient conversion of dietary linoleic acid and alpha-linolenic acid into their long-chain forms — arachidonic acid, EPA, and DHA. Population frequencies vary substantially by ancestry: the C allele is most common in South Asian populations (~82%) and less common in East Asian and Latino populations (~45%).
One T allele — moderately reduced FADS2 activity and PUFA conversion
You carry one copy of the reference C allele and one copy of the alternate T allele at rs99780. This is the most common genotype globally, present in about 48% of people. The T allele is associated with reduced FADS2 (delta-6 desaturase) expression and activity, meaning your conversion of plant-based omega-3 (ALA → EPA) and omega-6 (LA → ARA) fatty acids is modestly impaired compared to CC homozygotes. You will typically have somewhat higher circulating linoleic acid and lower arachidonic acid and EPA than CC carriers.
Two T alleles — substantially reduced FADS2 activity and impaired long-chain PUFA synthesis
You carry two copies of the T allele at rs99780, associated with the lowest FADS2 (delta-6 desaturase) activity at this locus. About 15% of people globally carry this genotype, though it is considerably more common in East Asian and Latino populations (~30%). Your conversion of dietary short-chain polyunsaturated fats into long-chain forms is substantially impaired: less linoleic acid (LA) reaches arachidonic acid (ARA), and less alpha-linolenic acid (ALA) is converted to EPA. As a result, your circulating ARA and EPA levels are likely lower than in CC carriers, while LA and ALA tend to accumulate as precursors.